Author: Zacks Small Cap Research

1525354555666540 / 657 POSTS
By David Bautz, PhDTSX:ATE.VFinancial UpdateOn April 3, 2018, Antibe Therapeutics Inc. (TSX:ATE.V) announced that following the successful completion of the Phase 2b gastrointestinal safety study and release of positive topline results, the company h ...
By John Vandermosten, CFANASDAQ:RXIIOn March 26, 2018, RXi Pharmaceuticals (NASDAQ:RXII) reported fourth quarter and full year 2017 results in conjunction with the filing of their 2017 10-K. RXi reported revenues of $15,000 for the year from grants r ...
By Anita DushyanthNASDAQ:MYOSHeadquartered in Cedar Knolls, NJ, MYOS RENS Technology Inc. (NASDAQ:MYOS) is an emerging advanced nutrition and biotherapeutics company. Their business is focused on developing and commercializing nutritional supplements ...
By John Vandermosten, CFANASDAQ:LPCN2017 Operational and Financial ResultsLipocine Inc. (NASDAQ:LPCN) filed its 2017 10-K and posted its earnings release on March 12, summarizing an volatile year which included new dosing studies for Tlando and a res ...
By Lisa ThompsonNASDAQ:CSSESince the acquisition of Screen Media on November 3rd of last year, Chicken Soup for the Soul Entertainment (NASDAQ:CSSE) has moved from being strictly a producer of original content, to a content distributor and web based ...
By Brian Marckx, CFANASDAQ:VIVEViveve (NASDAQ:VIVE) reported Q4 2017 results and provided a business update. Management also reiterated their previously issued 2018 revenue guidance in the range of $22M and $24M (inline with our prior and current ex ...
By Steven Ralston, CFANASDAQ:IFMKiFresh Inc. (NASDAQ:IFMK) is a specialty Chinese/Asian grocery chain that owns and operates nine retail supermarkets, located primarily in the Greater New York City (five stores) and Greater Boston (two stores) areas, ...
By David Bautz, PhDNYSE:APHBBusiness UpdatePositive Interim Results for Single-Patient Expanded Access ProgramOn January 3, 2018, AmpliPhi Biosciences Corp. (NYSE:APHB) announced positive interim results from the company’s single-patient expanded acc ...
By David Bautz, PhD NASDAQ:SPHSBusiness UpdateSophiris Bio Inc. (NASDAQ:SPHS) is developing treatments for localized clinically significant prostate cancer and lower urinary tract symptoms of benign prostatic hyperplasia (BPH). The company’s lead ca ...
OTC:BSGMIn the last 3 months there have been 18 Open Market Buys recorded with the SEC regarding Insider Activity for BioSig Technologies (OTC:BSGM). Director Patrick Joseph Gallagher bought 20,000 shares of BioSig Technologies stock in a transaction ...
1525354555666540 / 657 POSTS